Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-25-004459
Filing Date
2025-04-28
Accepted
2025-04-28 11:53:06
Documents
2
Period of Report
2025-04-24

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 4034
2 sgpoa24n.htm EX-24 6485
  Complete submission text file 0001225208-25-004459.txt   12013
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Issuer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
Gottlieb Scott (Reporting) CIK: 0001411359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03619 | Film No.: 25877966